The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
After 2015: infectious diseases in a new era of health and development
Open accessAbstract
Running over timescales that span decades or centuries, the epidemiological transition provides the central narrative of global health. In this transition, a reduction in mortality is followed by a reduction in fertility, creating larger, older populations in which the main causes of illness and death are no longer acute infections of children but chronic diseases of adults. Since the year 2000, the Millennium Development Goals (MDGs) have provided a framework for accelerating the decline of infectious diseases, backed by a massive injection of foreign investment to low-income countries. Despite the successes of the MDGs era, the inhabitants of low-income countries still suffer an enormous burden of disease owing to diarrhoea, pneumonia, HIV/AIDS, tuberculosis, malaria and other pathogens. Adding to the predictable burden of endemic disease, the threat of pandemics is ever-present and global. With a view to the future, this review spotlights five aspects of the fight against infection beyond 2015, when the MDGs will be replaced by a new set of goals for poverty reduction and sustainable development. These aspects are: exploiting the biological links between infectious and non-infectious diseases; controlling infections among the new urban majority; enhancing the response to international health threats; expanding childhood immunization programmes to prevent acute and chronic diseases in adults; and working towards universal health coverage. By scanning the wider horizon now, infectious disease specialists have the chance to shape the post-2015 era of health and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
The Epidemiologic Transition: A Theory of the Epidemiology of Population Change
OMRAN, A. R. (2005) · The Milbank Quarterly · doi:10.1111/j.1468-0009.2005.00398.x · Cited by 3,823
Stowman, K. (1949) · The Milbank Memorial Fund Quarterly · doi:10.2307/3348165 · Cited by 2,096
Host Range and Emerging and Reemerging Pathogens
Woolhouse, M. E. J., & Gowtage-Sequeria, S. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1112.050997 · Cited by 1,586
Jeon, C. Y., & Murray, M. B. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050152 · Cited by 1,486
Disease Control Priorities in Developing Countries
Mosley, W. H. (1993) · World Bank, Washington, DC eBooks · doi:10.1596/0-1952-0990-7 · Cited by 1,400
Dawood, F. S., Iuliano, A. D., Reed, C., Meltzer, M. I., Shay, D. K., Cheng, P.-Y., Bandaranayake, D., Breiman, R. F., Brooks, W. A., Buchy, P., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70121-4 · Cited by 1,363
Health systems financing and the path to universal coverage
Evans, D. B., & Etienne, C. (2010) · Bulletin of the World Health Organization · doi:10.2471/blt.10.078741 · Cited by 1,279
Cited by
Health and climate change: policy responses to protect public health
Watts, N., Adger, W. N., Agnolucci, P., Blackstock, J., Byass, P., Cai, W., Chaytor, S., Colbourn, T., Collins, M., Cooper, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60854-6 · Cited by 2,055
Watts, N., Amann, M., Ayeb-Karlsson, S., Belesova, K., Bouley, T., Boykoff, M., Byass, P., Cai, W., Campbell-Lendrum, D., Chambers, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32464-9 · Cited by 1,236
Electrochemical biosensors for pathogen detection
Cesewski, E., & Johnson, B. N. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112214 · Cited by 902
A review on graphene-based nanocomposites for electrochemical and fluorescent biosensors
Krishnan, S. K., Singh, E., Singh, P., Meyyappan, M., & Nalwa, H. S. (2019) · RSC Advances · doi:10.1039/c8ra09577a · Cited by 785
Modeling infectious disease dynamics in the complex landscape of global health
Heesterbeek, H., Anderson, R. M., Andreasen, V., Bansal, S., De Angelis, D., Dye, C., Eames, K. T. D., Edmunds, W. J., Frost, S. D. W., Funk, S., et al. (2015) · Science · doi:10.1126/science.aaa4339 · Cited by 690
Self-citationNanoparticle Vaccines Against Infectious Diseases
Pati, R., Shevtsov, M., & Sonawane, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02224 · Cited by 514
Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
Younes, N., Al-Sadeq, D. W., AL-Jighefee, H., Younes, S., Al-Jamal, O., Daas, H. I., Yassine, H. M., & Nasrallah, G. K. (2020) · Viruses · doi:10.3390/v12060582 · Cited by 410
Nugent, R., Bertram, M. Y., Jan, S., Niessen, L. W., Sassi, F., Jamison, D. T., Pier, E. G., & Beaglehole, R. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30667-6 · Cited by 373
Anti-infective Properties of the Golden Spice Curcumin
Praditya, D., Kirchhoff, L., Brüning, J., Rachmawati, H., Steinmann, J., & Steinmann, E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00912 · Cited by 373
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges
Nii-Trebi, N. I. (2017) · BioMed Research International · doi:10.1155/2017/5245021 · Cited by 356
Mba, I. E., & Nweze, E. I. (2021) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-021-03070-x · Cited by 321
Vazquez-Muñoz, R., Meza-Villezcas, A., Fournier, P. G. J., Soria-Castro, E., Juarez-Moreno, K., Gallego-Hernández, A. L., Bogdanchikova, N., Vazquez-Duhalt, R., & Huerta-Saquero, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224904 · Cited by 307
Banerjee, R., & Jaiswal, A. (2018) · The Analyst · doi:10.1039/c8an00307f · Cited by 265
Gandra, S., Alvarez-Uria, G., Turner, P., Joshi, J., Limmathurotsakul, D., & van Doorn, H. R. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-19 · Cited by 260
Godman, B., Haque, M., McKimm, J., Abu Bakar, M., Sneddon, J., Wale, J., Campbell, S., Martin, A. P., Hoxha, I., Abilova, V., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2019.1700947 · Cited by 171
Metadata
- Authors
- Dye, C.
- Venue
- Philosophical Transactions of the Royal Society B: Biological Sciences
- Publisher
- The Royal Society
- Published
- 2014-06-19
- Volume
- 369
- Issue
- 1645
- Pages
- 20130426
- ISSN
- 0962-8436 (ISSN-L)
- 1471-2970
- OpenAlex
- W2146770978
- Cited by
- 361
- References
- 55
- FWCI
- 28.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.